Clinical Trials Directory

Trials / Completed

CompletedNCT01463293

B. Lactis HN019 for Functional Constipation

Effects of 4-week Bifidobacterium Lactis HN019 Supplementation on Whole Gut Transit Time and Gastrointestinal Symptoms in Adults With Constipation: A Double-blind, Randomized, Placebo-controlled Dose-ranging Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
224 (actual)
Sponsor
Fonterra Research Centre · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the effects of 4-week probiotic supplementation on whole gut transit time and gastrointestinal symptoms in adults with functional constipation.

Detailed description

This prospective, double-blind, randomized, placebo-controlled clinical trial will investigate the effects of 4-week B. lactis HN019 supplementation on whole gut transit time and gastrointestinal symptoms in adults with functional constipation. Participants who meet all study entry criteria will enter a 2-week run-in period. Following successful completion of the run-in period, subjects will be randomized to 4-week supplementation with B. lactis HN019 (10 billion cfu), B. lactis HN019 (1 billion cfu), or placebo. The primary outcome of whole gut transit time will be evaluated with abdominal x-rays on days 0 and 28. Secondary outcomes include IBS-specific questionnaires (administered on days 0 and 28); abdominal pain severity, bowel movement frequency, stool consistency, and adverse events (evaluated daily throughout the study); and overall product satisfaction (evaluated at day 28). Physical activity questionnaires and 24-hour food recalls will be completed periodically during the trial.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTB. lactis HN019Capsule containing 10 billion cfu B. lactis HN019 once a day
DIETARY_SUPPLEMENTB. lactis HN019Capsule containing 1 billion cfu B. lactis HN019 once a day
DIETARY_SUPPLEMENTPlaceboCapsule containing no probiotic once a day

Timeline

Start date
2012-03-01
Primary completion
2013-03-01
Completion
2013-05-01
First posted
2011-11-01
Last updated
2014-07-24
Results posted
2014-07-24

Locations

12 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01463293. Inclusion in this directory is not an endorsement.